Tim Vanmierlo (T.)

van Veggel, L., Schepers, M., Tiane, A., Kumar, V., Willems, E., Rombaut, B., Noordijk, J., Vangansewinkel, T., Li, A., Wolfs, E., Ozcan, B., Nouboers, E., Moya, P. R., Sauer, D. B., Diliën, H., Hellings, N., Schreiber, R., & Vanmierlo, T. (2025). EAAT3 modulation: A potential novel avenue towards remyelination in multiple sclerosis. Biomedicine & Pharmacotherapy, 186, 117960. Article 117960. https://doi.org/10.1016/j.biopha.2025.117960

Schepers, M., Vangansewinkel, T., Libberecht, K., Jeurissen, H., Jacobs, D., Piccart, E., Prior, R., Ricciarelli, R., Brullo, C., Fedele, E., Bruno, O., Prickaerts, J., Lambrichts, I., Van Den Bosch, L., Vanmierlo, T., & Wolfs, E. (2025). Phosphodiesterase 4D inhibition improves the functional and molecular outcome in a mouse and human model of Charcot Marie Tooth disease 1 A. Biomedicine & Pharmacotherapy, 183, Article 117828. https://doi.org/10.1016/j.biopha.2025.117828

Van Broeckhoven, J., Mussen, F., Schepers, M., Vanmierlo, T., & Hellings, N. (2025). A new player in the game: identification of C1ql1 as a novel factor driving OPC differentiation. FEBS Journal, 292(1), 47-51. https://doi.org/10.1111/febs.17321

Schuetz, L. T., Duran, G., Baeten, P., Lintsen, D., Hermans, D., Chenine, S., Verreycken, J., Vanmierlo, T., Wouters, K., & Broux, B. (2024). Sex differentially affects pro-inflammatory cell subsets in adipose tissue depots in a diet induced obesity model. Biology of Sex Differences, 15(1), Article 105. https://doi.org/10.1186/s13293-024-00677-1

Vanbrabant, K., Rasking, L., Vangeneugden, M., Bove, H., Ameloot, M., Vanmierlo, T., Schins, R. P. F., Cassee, F. R., & Plusquin, M. (2024). Impact on murine neurodevelopment of early-life exposure to airborne ultrafine carbon nanoparticles. Particle and Fibre Toxicology, 21(1), Article 51. https://doi.org/10.1186/s12989-024-00612-7

Donders, Z., Skorupska, I. J., Willems, E., Mussen, F., Broeckhoven, J. V., Carlier, A., Schepers, M., & Vanmierlo, T. (2024). Beyond PDE4 inhibition: A comprehensive review on downstream cAMP signaling in the central nervous system. Biomedicine & Pharmacotherapy, 177, Article 117009. https://doi.org/10.1016/j.biopha.2024.117009

Leenders, F., Koole, L., Slaets, H., Tiane, A., Hove, D. V. D., & Vanmierlo, T. (2024). Navigating oligodendrocyte precursor cell aging in brain health. Mechanisms of Ageing and Development, 220, Article 111959. https://doi.org/10.1016/j.mad.2024.111959

Schepers, M., Hendrix, S., Mussen, F., van Breedam, E., Ponsaerts, P., Lemmens, S., Hellings, N., Ricciarelli, R., Fedele, E., Bruno, O., Brullo, C., Prickaerts, J., Van Broeckhoven, J., & Vanmierlo, T. (2024). Amelioration of functional and histopathological consequences after spinal cord injury through phosphodiesterase 4D (PDE4D) inhibition. Neurotherapeutics, 21(4), Article e00372. https://doi.org/10.1016/j.neurot.2024.e00372

Sin, Y. Y., Cameron, R. T., Schepers, M., MacLeod, R., Wright, T. A., Paes, D., van den Hove, D., Willems, E., Vanmierlo, T., Prickaerts, J., Blair, C. M., & Baillie, G. S. (2024). Beta-amyloid interacts with and activates the long-form phosphodiesterase PDE4D5 in neuronal cells to reduce cAMP availability. Febs Letters, 598(13), 1591-1604. https://doi.org/10.1002/1873-3468.14902

van Veggel, L., Voets, A. M., Vanmierlo, T., & Schreiber, R. (2024). Insights from an academic endeavor into central nervous system drug discovery. Neural Regeneration Research, 20(6), 1717-1718. https://doi.org/10.4103/NRR.NRR-D-24-00340